艾司奥美拉唑联合马来酸曲美布汀治疗老年性胃食管反流病的效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (759 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Esomeprazole combined with Trimebutin Maleate in the treatment of geriatric gastroesophageal reflux disease.Methods A total of 84 patients with geriatric gastroesophageal reflux disease admitted to Longgang Central Hospital of Shenzhen City from February 2018 to February 2020 were selected as the research subjects,and they were divided into the study group (42 cases) and the control group (42 cases) according to random number table method.The study group was treated with Esomeprazole combined with Trimebutin Maleate,while the control group was treated with Esomeprazole monotherapy.Both groups were treated for 8 weeks.Symptom score,quality of life score,gastroscopic efficacy,the level of serum motilin and gastrin-17 were compared between the two groups before and after treatment.Results There were no statistical significance in the symptom scores and quality of life scores of the two groups before treatment (P＞0.05).After treatment,symptom score of the two groups were lower than those before treatment,quality of life score of the two groups were higher than those before treatment,and the symptom score of the study group was lower than the control group,quality of life score of the study group was higher than the control group,the differences were statistically significant (P＜0.05).After treatment,the total effective rate under gastroscopy in the study group was higher than that in the control group,the difference was statistically significant(P＜0.05).Before treatment,there were no significant differences in the levels of serum motilin and serum gastrin-17 between the two groups (P＞0.05).After treatment,the levels of serum motilin in the two groups were higher than those before treatment,and the levels of serum gastrin-17 in the two groups were lower than those before treatment,and the level of serum motilin in the study group was higher than that in the control group,and the level of serum gastrin-17 in the study group was lower than that in the control group,the differences were statistically significant (P＜0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P＞0.05).Conclusion Esomeprazole combined with Trimebutin Maleate in the treatment of geriatric gastroesophageal reflux disease is effective,which can effectively improve the clinical symptoms,improve the quality of life.

Key words： Esomeprazole Trimebutine maleate Geriatric Gastroesophageal reflux disease Serum motilin Serum gastrin-17

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Chuantie
	ZENG Xiaohui

Cite this article:

CHEN Chuantie,ZENG Xiaohui. Effect of Esomeprazole combined with Trimebutine Maleate in the treatment of geriatric gastroesophageal reflux disease[J]. 中国当代医药, 2022, 29(3): 71-73转77.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I3/71

[2]	陈旻湖，侯晓华，肖英莲，等.2014年中国胃食管反流病专家共识意见[J].中华消化杂志，2014，34（10）：649-661.
[1]	Eusebi LH，Ratnakumaran R，Yuan Y，et al.Global prevalence of，and risk factors for，gastro-oesophageal reflux symptoms：a meta-analysis[J].Gut，2018，67（3）：430-440.
[3]	苏雪梅，孙银平.老年胃食管反流病患者夜间反流与睡眠障碍的关系分析[J].中国现代医生，2020，58（14）：46-48.
[4]	胡祥鹏，张深深，王乔，等.胃食管反流病重叠消化不良的临床及精神心理特征研究[J].中华全科医学，2019，17（9）：1447-1550.
[5]	MaretOuda J，Markar S，Lagergren J.Gastroesophageal reflux disease：a review[J].JAMA，2020，324（24）：2536-2547.
[6]	王薇，石蕾，许乐.马来酸曲美布汀治疗老年反流性食管炎患者中的疗效观察[J].中华老年医学杂志，2016，35（5）：511-516.
[7]	刘鹤婷，尚占民，黄皖农，等.马来酸曲美布汀对伴有无效食管动力的胃食管反流病患者食管运动功能的影响[J].临床消化病杂志.2016，28（3）：170-174.
[8]	王松，肖丹，陈兰，等.曲美布汀联合质子泵抑制剂以及益生菌对胃食管反流病患者临床疗效及肠道菌群的影响[J].临床消化病杂志，2019，31（6）：349-353.
[9]	倪德龙，马善美，郑卫.分析曲美布汀联合质子泵抑制剂对胃食管反流病患者食管远端平滑肌运动功能的影响[J].海峡药学，2020，32（5）：94-96.
[10]	黄焕深，林焕雄.中青年和老年胃食管反流病临床特征差异比较分析[J].中国临床新医学，2019，12（4）：88-90.
[11]	刘敏.雷贝拉唑联合马来酸曲美布汀治疗胃食管反流病的临床疗效[J].中国实用医药，2021，16（21）：148-150.
[12]	焦徳军.探讨埃索美拉唑与莫沙必利联合治疗反流性食管炎的临床疗效[J].当代医学，2020，26（27）：117-119.
[13]	曹绍华，高学德，张金冉，等.CYP2C19 基因多态性与胃食管反流病质子泵抑制剂治疗疗效的关系[J].现代消化及介入诊疗，2020，25（7）：889-892.
[14]	李远，杨飏.埃索美拉唑与奥美拉唑对反流性食管炎的治疗效果[J].吉林医学，2020，41（9）：2177-2178.
[15]	余中禄.曲美布汀联合莫沙必利对功能性消化不良患者胃肠激素及胃肠动力的影响[J].临床医学，2019，39（5）：112-114.
[16]	黄欣，王萍.莫沙必利联合马来酸曲美布汀治疗功能性消化不良的疗效观察[J].临床消化病杂志，2017，29（2）：65-68.
[17]	王颖.马来酸曲美布汀与埃索美拉唑联合治疗胃食管反流病的临床疗效及安全性分析[J].中国现代药物应用，2021，15（2）：118-120.
[18]	邓瑞华，邹杏坚.艾司奥美拉唑联合马来酸曲美布汀治疗胃食管反流病的疗效观察[J].深圳中西医结合杂志，2018，28（10）：109-110.